Last update 21 Nov 2024

RMC-4630

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
SHP2, Vociprotafib, Vociprotafib(USAN)
+ [3]
Target
Mechanism
SHP2 inhibitors(Src homology phosphotyrosyl phosphatase 2 inhibitors)
Originator Organization
Active Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC20H27ClN6O2S
InChIKeyHISJAYUQVHMWTA-BLLLJJGKSA-N
CAS Registry2172652-48-9

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Neoplasm MetastasisPhase 2
ES
09 Jun 2020
Neoplasm MetastasisPhase 2
TW
09 Jun 2020
Neoplasm MetastasisPhase 2
NL
09 Jun 2020
Neoplasm MetastasisPhase 2
TW
09 Jun 2020
Neoplasm MetastasisPhase 2
NL
09 Jun 2020
Neoplasm MetastasisPhase 2
US
09 Jun 2020
Neoplasm MetastasisPhase 2
AR
09 Jun 2020
Neoplasm MetastasisPhase 2
ES
09 Jun 2020
Neoplasm MetastasisPhase 2
KR
09 Jun 2020
Colorectal CancerPhase 2
JP
28 Nov 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
113
(Intermittent RMC-4630 80mg (D1D4) + Cobimetinib 20mg QD (21/7))
cbhtnsdkwi(qgvralkicu) = upbxableng chqmssoupl (dbhyxncsak, hgecxukyja - bidsefgycg)
-
26 Jun 2023
(Intermittent RMC-4630 80mg (D1D4) + Cobimetinib 40mg QD (21/7))
cbhtnsdkwi(qgvralkicu) = oykcsjfvze chqmssoupl (dbhyxncsak, lswhcrpmpx - ckqbzkixbb)
Phase 1
Solid tumor
KRAS Mutation
104
overall
(ulixyogmqb) = 200 mg D1D2, delivering a 400 mg weekly dose intensity oxybndqepq (aqmvmnonyj )
Positive
10 Apr 2021
(KRAS MUT NSCLC)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free